Dr. Annarita Miccio, Lab Director of the Laboratory of Chromatin and Gene Regulation during Development at the Imagine Institute, Paris (France)

Dr. Annarita Miccio is the Director of the Laboratory of Chromatin and Gene Regulation during Development at the Imagine Institute (Paris Cite’ University, INSERM Unit UMR1163) in Paris. Her primary research focuses on the transcriptional control of hematopoiesis and developing therapies for β-hemoglobinopathies. During her PhD, she created a lentiviral vector used in an early β-thalassemia clinical trial. As a post-doc and assistant professor, she specialized in gene regulation during erythroid development and gene therapy for hematopoietic disorders. Appointed Lab Director in 2014, Dr. Miccio continued her research on transcriptional regulation in stem cells, advancing therapies for β-hemoglobinopathies. She optimized lentiviral vectors for a sickle cell disease clinical trial and developed CRISPR/Cas9 strategies. Dr. Miccio has authored over 50 publications and 15 patents, coordinated numerous projects, and received several awards, including two Sanofi Innovation awards and the ASGCT Outstanding New Investigator Award.

Annarita is a member of CA21113 Working Groups 3 and 5!